Background: Premenstrual syndrome (PMS) alludes to a cyclic advent of somatic and psychiatric symptoms that affect some women of reproductive age. Some studies demonstrated that vitamin D was associated with premenstrual symptoms. Objective: The aim of this study was to evaluate the effect of vitamin D supplementation in the treatment of PMS in vitamin D-deficient young girls. Methods: In this randomized double-blind placebo-controlled trial, 130 vitamin D-deficient girls aged 18–30 years, with PMS, were randomly divided into 2 groups and received a 2,000 IU vitamin D tablet (n = 64) or a placebo (n = 66) every other day for 12 weeks. At the beginning and at the end of week 12, serum 25(OH)-D, premenstrual symptoms, anthropometric indices, dietary intake, physical activity level, and sun exposure were evaluated. Statistical analysis was performed using SPSS version 20. p < 0.05 was considered statistically significant. Results: Serum 25(OH)-D levels were significantly elevated in the vitamin D group in comparison to the placebo group after 12 weeks (p < 0.001). There was no significant difference between the 2 groups with regard to 14 symptoms of PMS after 12 weeks of intervention, even after adjustment for the baseline values of anxiety, weeping, and hypersomnia (for all symptoms, p > 0.05). However, in the vitamin D group, scores of nervousness (p < 0.001), job activity reduction (p = 0.01), social activity reduction (p = 0.01), fatigue (p < 0.001), and physical symptoms (p = 0.00) were reduced at the end of the intervention, and these changes were statistically significant compared to baseline. However, these alterations did not reach significance compared with the placebo group (p > 0.05). Conclusion: It seems that 2,000 IU vitamin D consumption in the vitamin D-deficient young girls with PMS every other day for 12 weeks had no significant impact on other PMS symptoms.

1.
Tartagni
M
,
Cicinelli
MV
,
Tartagni
MV
,
Alrasheed
H
,
Matteo
M
,
Baldini
D
, et al.
Vitamin D Supplementation for Premenstrual Syndrome-Related Mood Disorders in Adolescents with Severe Hypovitaminosis D
.
J Pediatr Adolesc Gynecol
.
2016
Aug
;
29
(
4
):
357
61
.
[PubMed]
1083-3188
2.
Shehata
NA
.
Calcium versus oral contraceptive pills containing drospirenone for the treatment of mild to moderate premenstrual syndrome: a double blind randomized placebo controlled trial
.
Eur J Obstet Gynecol Reprod Biol
.
2016
Mar
;
198
:
100
4
.
[PubMed]
0301-2115
3.
Bertone-Johnson
ER
,
Hankinson
SE
,
Forger
NG
,
Powers
SI
,
Willett
WC
,
Johnson
SR
, et al.
Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study
.
BMC Womens Health
.
2014
Apr
;
14
(
1
):
56
.
[PubMed]
1472-6874
4.
Bertone-Johnson
ER
,
Powers
SI
,
Spangler
L
,
Larson
J
,
Michael
YL
,
Millen
AE
, et al.
Vitamin D supplementation and depression in the women’s health initiative calcium and vitamin D trial
.
Am J Epidemiol
.
2012
Jul
;
176
(
1
):
1
13
.
[PubMed]
0002-9262
5.
Bertone-Johnson
ER
.
Vitamin D and the occurrence of depression: causal association or circumstantial evidence?
Nutr Rev
.
2009
Aug
;
67
(
8
):
481
92
.
[PubMed]
0029-6643
6.
Armstrong
DJ
,
Meenagh
GK
,
Bickle
I
,
Lee
AS
,
Curran
ES
,
Finch
MB
.
Vitamin D deficiency is associated with anxiety and depression in fibromyalgia
.
Clin Rheumatol
.
2007
Apr
;
26
(
4
):
551
4
.
[PubMed]
0770-3198
7.
Lasco
A
,
Catalano
A
,
Benvenga
S
.
Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-controlled study
.
Arch Intern Med
.
2012
Feb
;
172
(
4
):
366
7
.
[PubMed]
0003-9926
8.
Paffoni
A
,
Somigliana
E
,
Vigano’
P
,
Benaglia
L
,
Cardellicchio
L
,
Pagliardini
L
, et al.
Vitamin D status in women with uterine leiomyomas
.
J Clin Endocrinol Metab
.
2013
Aug
;
98
(
8
):
E1374
8
.
[PubMed]
0021-972X
9.
Baird
DD
,
Hill
MC
,
Schectman
JM
,
Hollis
BW
.
Vitamin d and the risk of uterine fibroids
.
Epidemiology
.
2013
May
;
24
(
3
):
447
53
.
[PubMed]
1044-3983
10.
Sohrabi
N
,
Kashanian
M
,
Ghafoori
SS
,
Malakouti
SK
.
Evaluation of the effect of omega-3 fatty acids in the treatment of premenstrual syndrome: “a pilot trial”
.
Complement Ther Med
.
2013
Jun
;
21
(
3
):
141
6
.
[PubMed]
0965-2299
11.
Schulz
KF
,
Altman
DG
,
Moher
D
;
CONSORT Group
.
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
.
BMC Med
.
2010
Mar
;
8
(
1
):
18
.
[PubMed]
1741-7015
12.
Craig
CL
,
Marshall
AL
,
Sjöström
M
,
Bauman
AE
,
Booth
ML
,
Ainsworth
BE
, et al.
International physical activity questionnaire: 12-country reliability and validity
.
Med Sci Sports Exerc
.
2003
Aug
;
35
(
8
):
1381
95
.
[PubMed]
0195-9131
13.
Abiri
B
,
Vafa
MR
,
Dehghani
M
,
Moslehi
N
,
Sarrafzadeh
J
.
Effect of Vitamin D Supplement Consumption on Muscle Strength, Muscle Function and Body Composition in Vitamin D-deficient Middle-aged Women: A Randomized Clinical Trial
.
Nutrition and Food Sciences Research.
2016
Jul
;
3
(
3
):
17
24
.
14.
Siyah Bazi Sh
.
Hariri F, Montazeri A, the front bell. Standardization of premenstrual symptoms screening questionnaire PSST: translation and psychometric Iranian species
.
[Persian]
.
Monitoring.
2011
;
10
(
4
):
421
7
.
15.
Obeidat
BA
,
Alchalabi
HA
,
Abdul-Razzak
KK
,
Al-Farras
MI
.
Premenstrual symptoms in dysmenorrheic college students: prevalence and relation to vitamin D and parathyroid hormone levels
.
Int J Environ Res Public Health
.
2012
Nov
;
9
(
11
):
4210
22
.
[PubMed]
1661-7827
16.
Bertone-Johnson
ER
,
Chocano-Bedoya
PO
,
Zagarins
SE
,
Micka
AE
,
Ronnenberg
AG
.
Dietary vitamin D intake, 25-hydroxyvitamin D3 levels and premenstrual syndrome in a college-aged population
.
J Steroid Biochem Mol Biol
.
2010
Jul
;
121
(
1-2
):
434
7
.
[PubMed]
0960-0760
17.
Khajehei
M
,
Abdali
K
,
Parsanezhad
ME
,
Tabatabaee
HR
.
Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome
.
Int J Gynaecol Obstet
.
2009
May
;
105
(
2
):
158
61
.
[PubMed]
0020-7292
18.
Thys-Jacobs
S
,
McMahon
D
,
Bilezikian
JP
.
Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder
.
J Clin Endocrinol Metab
.
2007
Aug
;
92
(
8
):
2952
9
.
[PubMed]
0021-972X
19.
Penland
JG
,
Johnson
PE
.
Dietary calcium and manganese effects on menstrual cycle symptoms
.
Am J Obstet Gynecol
.
1993
May
;
168
(
5
):
1417
23
.
[PubMed]
0002-9378
20.
Thys-Jacobs
S
,
Starkey
P
,
Bernstein
D
,
Tian
J
;
Premenstrual Syndrome Study Group
.
Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms
.
Am J Obstet Gynecol
.
1998
Aug
;
179
(
2
):
444
52
.
[PubMed]
0002-9378
21.
Bertone-Johnson
ER
,
Hankinson
SE
,
Bendich
A
,
Johnson
SR
,
Willett
WC
,
Manson
JE
.
Calcium and vitamin D intake and risk of incident premenstrual syndrome
.
Arch Intern Med
.
2005
Jun
;
165
(
11
):
1246
52
.
[PubMed]
0003-9926
22.
Johnson
SR
.
The epidemiology and social impact of premenstrual symptoms
.
Clin Obstet Gynecol
.
1987
Jun
;
30
(
2
):
367
76
.
[PubMed]
0009-9201
23.
Mortola
JF
.
Issues in the diagnosis and research of premenstrual syndrome
.
Clin Obstet Gynecol
.
1992
Sep
;
35
(
3
):
587
98
.
[PubMed]
0009-9201
24.
Moini
A
,
Ebrahimi
T
,
Shirzad
N
,
Hosseini
R
,
Radfar
M
,
Bandarian
F
, et al.
The effect of vitamin D on primary dysmenorrhea with vitamin D deficiency: a randomized double-blind controlled clinical trial
.
Gynecol Endocrinol
.
2016
Jun
;
32
(
6
):
502
5
.
[PubMed]
0951-3590
25.
Bahrami
A
,
Avan
A
,
Sadeghnia
HR
,
Esmaeili
H
,
Tayefi
M
,
Ghasemi
F
, et al.
High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents
.
Gynecol Endocrinol
.
2018
Aug
;
34
(
8
):
659
63
.
[PubMed]
0951-3590
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.